Does INFLIXIMAB Cause Lung neoplasm malignant? 379 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 379 reports of Lung neoplasm malignant have been filed in association with INFLIXIMAB (Renflexis). This represents 0.3% of all adverse event reports for INFLIXIMAB.
379
Reports of Lung neoplasm malignant with INFLIXIMAB
0.3%
of all INFLIXIMAB reports
71
Deaths
91
Hospitalizations
How Dangerous Is Lung neoplasm malignant From INFLIXIMAB?
Of the 379 reports, 71 (18.7%) resulted in death, 91 (24.0%) required hospitalization, and 19 (5.0%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 379 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
BUDESONIDE\FORMOTEROL (353)
FLUTICASONE\SALMETEROL (345)
Which INFLIXIMAB Alternatives Have Lower Lung neoplasm malignant Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT